Cord Blood Banking Services Market Report 2026

The cord blood banking services market size has grown strongly in recent years. It will grow from $28.57 billion in 2025 to $30.54 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to limited treatment alternatives for genetic disorders, early adoption of stem cell therapies, growing childbirth rates in urban areas, hospital-based collection models, increasing family health awareness.

The cord blood banking services market size is expected to see strong growth in the next few years. It will grow to $39.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to advancements in regenerative medicine, expanding therapeutic applications of stem cells, rising disposable incomes, growth in private healthcare services, increasing clinical trials using cord blood. Major trends in the forecast period include rising preference for private cord blood banking, increasing awareness of stem cell therapies, expansion of cord tissue banking services, growing parental education programs, integration of long-term storage solutions.

The rising prevalence of genetic disorders is expected to drive the growth of the cord blood banking services market in the coming years. Genetic disorders are conditions that result from abnormalities in an individual’s DNA, often caused by mutations or alterations in gene sequences. The increasing occurrence of these disorders is linked to improvements in diagnostic technologies that enhance detection rates, along with increasing maternal age, which raises the likelihood of genetic mutations. Cord blood banking provides an important source of stem cells that can be used in the treatment of genetic disorders through transplants and potential future gene therapy applications. For example, in June 2023, Gene People, a UK-based registered charity supporting individuals with genetic conditions, reported that one in every 25 children in the UK was affected by a genetic disorder, impacting around 30,000 newborns and young children, as well as more than 2.4 million children and adults each year. As a result, the growing prevalence of genetic disorders is contributing to the expansion of the cord blood banking services market.

Companies operating in the cord blood banking services market are increasingly focused on developing advanced solutions such as modern cord blood banking facilities to improve stem cell viability and therapeutic effectiveness. Cord blood banking facilities are specialized centers that offer services for the collection, processing, and storage of umbilical cord blood. For instance, in August 2024, Future Health GCC, a UAE-based stem cell bank, launched an advanced cord blood banking facility in Dubai Healthcare City, allowing families to store their newborn’s umbilical cord blood, which is rich in stem cells. This non-invasive collection process takes place immediately after birth and provides a valuable resource for treating a range of serious medical conditions. The facility is equipped with advanced technologies and adheres to high safety standards to ensure optimal storage conditions. Compared with traditional stem cell sources, this approach is easier to collect and store, offering families a practical method to safeguard their children’s future health.

In July 2024, CytoMed Therapeutics Limited, a Singapore-based biopharmaceutical company, acquired Cellsafe International Sdn Bhd for an undisclosed amount. Through this acquisition, CytoMed sought to enhance its allogeneic cell therapy capabilities by obtaining access to a cord blood banking license issued by Malaysia’s Ministry of Health, cryopreservation infrastructure, and more than 12,000 cord blood units, along with two freehold operational properties. Cellsafe International Sdn Bhd is a Malaysia-based cord blood banking company that specializes in the storage and management of cryopreserved cord blood units for therapeutic use.

Major companies operating in the cord blood banking services market are PerkinElmer Inc, AMAG Pharmaceuticals Inc, China Cord Blood Corporation, LifeCell International Pvt. Ltd, Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, LifeBank, Cryo-Cell International, CryoSave SA, ViaCord Inc, Future Health Biobank, Virgin Health Bank, FamiCord Group, Maze Cord Blood Laboratories, Biovault Family, Cells4Life Group LLP, Americord Registry LLC, Angiocrine Bioscience Inc, California Cryobank Stem Cell Services LLC, Singapore Cord Blood Bank, StemCyte Inc, AlphaCord LLC.

North America was the largest region in the cord blood banking services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cord blood banking services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cord blood banking services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cord blood banking services market by increasing costs of imported cryopreservation equipment, storage containers, laboratory instruments, and consumables. Hospitals and private cord blood banks in North America and Europe are most affected due to reliance on imported processing technologies, while Asia-Pacific faces higher infrastructure costs. These tariffs are raising service prices. However, they are also encouraging local equipment manufacturing, regional laboratory development, and improved long-term biobanking infrastructure.

The cord blood banking services market research report is one of a series of new reports that provides cord blood banking services market statistics, including cord blood banking services industry global market size, regional shares, competitors with a cord blood banking services market share, detailed cord blood banking services market segments, market trends and opportunities, and any further data you may need to thrive in the cord blood banking services industry. This cord blood banking services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cord blood banking services involve the collection, storage, and preservation of blood obtained from the umbilical cord and placenta following childbirth. This blood contains a high concentration of stem cells that can be used to treat a wide range of medical conditions. Cord blood banking offers families a valuable medical resource for potential future treatments, providing reassurance and access to possible life-saving therapies.

The primary components of cord blood banking services include cord blood and cord tissue. Cord blood refers to the blood collected from the umbilical cord and placenta after delivery. Core services associated with cord blood banking include collection and transportation, processing, analysis, and storage, all of which are essential for supporting treatments across applications such as cancer, blood disorders, metabolic disorders, immune disorders, and others. These services are utilized by various end users, including hospitals, pharmaceutical research organizations, and research institutes.

The cord blood banking services market includes revenues earned by entities by providing services, such as collection of umbilical cord blood, cryopreservation, family banking services, testing, and customer support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.